JEFFREY WILLIAM GROVES
- Type
- Physician · Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Neurology
- Where
- DRAPER, UT
- NPI
- 1629196399
- Received
- $627,523 in 1,843 records, 2019 to 2025
- As principal investigator
- $16,452 of research payments to others in 5 records
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 276 | $90,379 |
| 2024 | General payment | 280 | $72,502 |
| 2023 | General payment | 331 | $68,803 |
| 2022 | General payment | 297 | $113,433 |
| 2021 | General payment | 285 | $144,256 |
| 2020 | General payment | 150 | $73,262 |
| 2019 | General payment | 224 | $64,886 |
By company
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 268 | $494,315 |
| Consulting Fee | 52 | $53,402 |
| Honoraria | 31 | $49,712 |
| Food and Beverage | 1,331 | $20,616 |
| Travel and Lodging | 151 | $9,286 |
| Education | 9 | $149 |
| Grant | 1 | $41 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-23 | Axsome Therapeutics, Inc. | $9 | Food and Beverage | In-kind items and services | Symbravo Drug, Neurology | 2025 | |
| 2025-12-22 | UCB, Inc. | $2,500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Rystiggo Drug, Neurology | 2025 | |
| 2025-12-22 | UCB, Inc. | $15 | Travel and Lodging | Cash or cash equivalent | Rystiggo Drug, Neurology | 2025 | |
| 2025-12-20 | Medtronic, Inc. | $61 | Food and Beverage | In-kind items and services | PERCEPT PC BRAINSENSE Device, Deep Brain Neurostimulation | 2025 | |
| 2025-12-17 | Amgen Inc. | $17 | Food and Beverage | In-kind items and services | UPLIZNA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-12-17 | PFIZER INC. | $10 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-12-15 | Mallinckrodt Hospital Products Inc. | $25 | Food and Beverage | In-kind items and services | ACTHAR Biological, IMMUNOLOGY | 2025 | |
| 2025-12-12 | ARGENX US, INC. | $9 | Food and Beverage | In-kind items and services | VYVGART HYTRULO Drug, Neurology | 2025 | |
| 2025-12-10 | Teva Pharmaceuticals USA, Inc. | $19 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-12-10 | PFIZER INC. | $11 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-12-08 | SK Life Science, Inc. | $20 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-12-04 | PFIZER INC. | $3,150 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-12-03 | UCB, Inc. | $2,500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Rystiggo Drug, Neurology | 2025 | |
| 2025-12-03 | UCB, Inc. | $2,500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Rystiggo Drug, Neurology | 2025 | |
| 2025-12-03 | UCB, Inc. | $840 | Consulting Fee | Cash or cash equivalent | Rystiggo Drug, Neurology | 2025 | |
| 2025-12-03 | UCB, Inc. | $60 | Travel and Lodging | Cash or cash equivalent | Rystiggo Drug, Neurology | 2025 | |
| 2025-12-03 | UCB, Inc. | $35 | Travel and Lodging | Cash or cash equivalent | Rystiggo Drug, Neurology | 2025 | |
| 2025-12-03 | PFIZER INC. | $13 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-12-03 | PFIZER INC. | $12 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-12-02 | LivaNova USA, Inc. | $70 | Travel and Lodging | Cash or cash equivalent | VNS Therapy Device, Neurology | 2025 | |
| 2025-12-02 | UCB, Inc. | $21 | Food and Beverage | In-kind items and services | Rystiggo Drug, Neurology | 2025 | |
| 2025-12-01 | PFIZER INC. | $3,150 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-12-01 | UCB, Inc. | $20 | Food and Beverage | In-kind items and services | Rystiggo Drug, Neurology | 2025 | |
| 2025-12-01 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-12-01 | Teva Pharmaceuticals USA, Inc. | $6 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-11-25 | Amgen Inc. | $16 | Food and Beverage | In-kind items and services | UPLIZNA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-11-25 | ARGENX US, INC. | $14 | Food and Beverage | In-kind items and services | VYVGART HYTRULO Drug, Neurology | 2025 | |
| 2025-11-20 | ARGENX US, INC. | $2,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VYVGART Drug, Immunology | 2025 | |
| 2025-11-20 | ARGENX US, INC. | $60 | Travel and Lodging | Cash or cash equivalent | VYVGART Drug, Immunology | 2025 | |
| 2025-11-20 | Neurocrine BioSciences, Inc. | $14 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-11-20 | Life Molecular Imaging Ltd | $10 | Food and Beverage | Cash or cash equivalent | NEURACEQ Drug, Diagnostic Tracer | 2025 | |
| 2025-11-19 | PFIZER INC. | $3,150 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-11-19 | PFIZER INC. | $11 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-11-18 | PFIZER INC. | $610 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZAVZPRET Drug, PAIN | 2025 | |
| 2025-11-18 | Medtronic, Inc. | $22 | Food and Beverage | In-kind items and services | SENSIGHT Device, Deep Brain Neurostimulation | 2025 | |
| 2025-11-18 | ABBVIE INC. | $16 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-11-17 | PFIZER INC. | $15 | Travel and Lodging | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-11-15 | LivaNova USA, Inc. | $267 | Food and Beverage | In-kind items and services | VNS Therapy Device, Neurology | 2025 | |
| 2025-11-14 | LivaNova USA, Inc. | $341 | Travel and Lodging | In-kind items and services | VNS Therapy Device, Neurology | 2025 | |
| 2025-11-14 | LivaNova USA, Inc. | $174 | Food and Beverage | In-kind items and services | VNS Therapy Device, Neurology | 2025 | |
| 2025-11-13 | PFIZER INC. | $13 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-11-12 | PFIZER INC. | $10 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-11-11 | ARGENX US, INC. | $16 | Food and Beverage | In-kind items and services | VYVGART HYTRULO Drug, Neurology | 2025 | |
| 2025-11-11 | Teva Pharmaceuticals USA, Inc. | $14 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-11-06 | Lundbeck LLC | $1,600 | Honoraria | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2025 | |
| 2025-11-06 | UCB, Inc. | $14 | Food and Beverage | In-kind items and services | Rystiggo Drug, Neurology | 2025 | |
| 2025-11-06 | Lundbeck LLC | $13 | Food and Beverage | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2025 | |
| 2025-11-05 | PFIZER INC. | $9 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-10-29 | PFIZER INC. | $11 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-10-28 | ARGENX US, INC. | $14 | Food and Beverage | In-kind items and services | VYVGART HYTRULO Drug, Neurology | 2025 | |
| 2025-10-27 | Teva Pharmaceuticals USA, Inc. | $16 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-10-27 | Teva Pharmaceuticals USA, Inc. | $3 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-10-23 | UCB, Inc. | $10 | Food and Beverage | In-kind items and services | Rystiggo Drug, Neurology | 2025 | |
| 2025-10-22 | PFIZER INC. | $10 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-10-17 | ARGENX US, INC. | $20 | Food and Beverage | In-kind items and services | VYVGART HYTRULO Drug, Neurology | 2025 | |
| 2025-10-16 | LivaNova USA, Inc. | $12 | Food and Beverage | In-kind items and services | VNS THERAPY SENTIVA MODEL 1000 GENERATOR Device, Neurology | 2025 | |
| 2025-10-15 | Lundbeck LLC | $1,245 | Consulting Fee | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2025 | |
| 2025-10-15 | Lundbeck LLC | $20 | Food and Beverage | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2025 | |
| 2025-10-15 | PFIZER INC. | $13 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-10-15 | PFIZER INC. | $3 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-10-14 | Mallinckrodt Hospital Products Inc. | $15 | Food and Beverage | In-kind items and services | ACTHAR Biological, IMMUNOLOGY | 2025 | |
| 2025-10-10 | PFIZER INC. | $3,150 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-10-09 | Neurocrine BioSciences, Inc. | $15 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-10-09 | PFIZER INC. | $8 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-10-08 | PFIZER INC. | $10 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-10-07 | PFIZER INC. | $3,150 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-10-07 | PFIZER INC. | $3,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-10-07 | Teva Pharmaceuticals USA, Inc. | $13 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-10-06 | UCB, Inc. | $840 | Consulting Fee | Cash or cash equivalent | Rystiggo Biological, Neurology | 2025 | |
| 2025-10-02 | ARGENX US, INC. | $1,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VYVGART Drug, Immunology | 2025 | |
| 2025-10-02 | ARGENX US, INC. | $23 | Travel and Lodging | Cash or cash equivalent | VYVGART Drug, Immunology | 2025 | |
| 2025-10-01 | Axsome Therapeutics, Inc. | $18 | Food and Beverage | In-kind items and services | Symbravo Drug, Neurology | 2025 | |
| 2025-10-01 | PFIZER INC. | $18 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-09-30 | Axsome Therapeutics, Inc. | $33 | Food and Beverage | In-kind items and services | Symbravo Drug, Neurology | 2025 | |
| 2025-09-30 | ARGENX US, INC. | $18 | Food and Beverage | In-kind items and services | VYVGART HYTRULO Drug, Neurology | 2025 | |
| 2025-09-30 | Amgen Inc. | $17 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-09-29 | Mallinckrodt Hospital Products Inc. | $24 | Food and Beverage | In-kind items and services | ACTHAR Biological, IMMUNOLOGY | 2025 | |
| 2025-09-29 | PFIZER INC. | $2 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-09-25 | PFIZER INC. | $1,525 | Consulting Fee | Cash or cash equivalent | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-09-25 | ARGENX US, INC. | $25 | Food and Beverage | In-kind items and services | VYVGART Drug, Immunology | 2025 | |
| 2025-09-25 | Neurelis, Inc. | $15 | Food and Beverage | In-kind items and services | VALTOCO Drug, EPILEPSY | 2025 | |
| 2025-09-24 | Lundbeck LLC | $13 | Food and Beverage | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2025 | |
| 2025-09-24 | UCB, Inc. | $11 | Food and Beverage | In-kind items and services | Rystiggo Drug, Neurology | 2025 | |
| 2025-09-24 | ABBVIE INC. | $7 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-09-23 | UCB, Inc. | $840 | Consulting Fee | Cash or cash equivalent | Rystiggo Biological, Neurology | 2025 | |
| 2025-09-23 | Lundbeck LLC | $44 | Consulting Fee | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2025 | |
| 2025-09-23 | Teva Pharmaceuticals USA, Inc. | $17 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-09-22 | PFIZER INC. | $1,525 | Consulting Fee | Cash or cash equivalent | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-09-18 | ABBVIE INC. | $3,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-09-17 | ARGENX US, INC. | $18 | Food and Beverage | In-kind items and services | VYVGART HYTRULO Drug, Neurology | 2025 | |
| 2025-09-17 | UCB, Inc. | $17 | Food and Beverage | In-kind items and services | Rystiggo Drug, Neurology | 2025 | |
| 2025-09-17 | PFIZER INC. | $10 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-09-16 | Lundbeck LLC | $2,400 | Consulting Fee | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2025 | |
| 2025-09-16 | SK Life Science, Inc. | $19 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-09-12 | PFIZER INC. | $10 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-09-11 | ABBVIE INC. | $1,625 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-09-11 | ABBVIE INC. | $15 | Travel and Lodging | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-09-11 | ABBVIE INC. | $0 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-09-07 | Lundbeck LLC | $608 | Consulting Fee | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2025 | |
| 2025-09-06 | Lundbeck LLC | $50 | Consulting Fee | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2025 | |
| 2025-09-06 | Lundbeck LLC | $37 | Consulting Fee | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2025 | |
| 2025-09-06 | Lundbeck LLC | $35 | Consulting Fee | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2025 | |
| 2025-09-06 | Lundbeck LLC | $23 | Consulting Fee | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2025 | |
| 2025-09-05 | Lundbeck LLC | $192 | Consulting Fee | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2025 | |
| 2025-09-05 | Lundbeck LLC | $124 | Consulting Fee | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2025 | |
| 2025-09-05 | Lundbeck LLC | $43 | Consulting Fee | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2025 | |
| 2025-09-05 | UCB, Inc. | $11 | Food and Beverage | In-kind items and services | Rystiggo Drug, Neurology | 2025 | |
| 2025-09-04 | ABBVIE INC. | $3,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-09-04 | PFIZER INC. | $8 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-09-04 | LivaNova USA, Inc. | $6 | Food and Beverage | In-kind items and services | VNS THERAPY SENTIVA MODEL 1000 GENERATOR Device, Neurology | 2025 | |
| 2025-09-04 | PFIZER INC. | $2 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-09-03 | UCB, Inc. | $13 | Food and Beverage | In-kind items and services | Rystiggo Drug, Neurology | 2025 | |
| 2025-08-28 | Axsome Therapeutics, Inc. | $11 | Food and Beverage | In-kind items and services | Symbravo Drug, Neurology | 2025 | |
| 2025-08-27 | UCB, Inc. | $10 | Food and Beverage | In-kind items and services | Rystiggo Drug, Neurology | 2025 | |
| 2025-08-27 | PFIZER INC. | $8 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-08-27 | PFIZER INC. | $7 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-08-26 | UCB, Inc. | $11 | Food and Beverage | In-kind items and services | Rystiggo Drug, Neurology | 2025 | |
| 2025-08-25 | ABBVIE INC. | $84 | Travel and Lodging | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-08-25 | ABBVIE INC. | $27 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-08-25 | Teva Pharmaceuticals USA, Inc. | $14 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-08-25 | ABBVIE INC. | $12 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-08-21 | ARGENX US, INC. | $2,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VYVGART Drug, Immunology | 2025 | |
| 2025-08-21 | Lundbeck LLC | $11 | Food and Beverage | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2025 | |
| 2025-08-20 | PFIZER INC. | $10 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-08-19 | ARGENX US, INC. | $13 | Food and Beverage | In-kind items and services | VYVGART HYTRULO Drug, Neurology | 2025 | |
| 2025-08-18 | Lundbeck LLC | $60 | Consulting Fee | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2025 | |
| 2025-08-07 | UCB, Inc. | $10 | Food and Beverage | In-kind items and services | Rystiggo Drug, Neurology | 2025 | |
| 2025-08-06 | Medtronic, Inc. | $18 | Food and Beverage | In-kind items and services | PERCEPT PC BRAINSENSE Device, Deep Brain Neurostimulation | 2025 | |
| 2025-08-05 | Lundbeck LLC | $1,600 | Honoraria | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2025 | |
| 2025-08-05 | UCB, Inc. | $200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Zilbrysq Drug, Neurology | 2025 | |
| 2025-07-30 | PFIZER INC. | $9 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-07-29 | ARGENX US, INC. | $12 | Food and Beverage | In-kind items and services | VYVGART HYTRULO Drug, Neurology | 2025 | |
| 2025-07-28 | UCB, Inc. | $27 | Food and Beverage | In-kind items and services | Rystiggo Drug, Neurology | 2025 | |
| 2025-07-28 | Medtronic, Inc. | $19 | Food and Beverage | In-kind items and services | PERCEPT PC BRAINSENSE Device, Deep Brain Neurostimulation | 2025 | |
| 2025-07-28 | UCB, Inc. | $6 | Food and Beverage | In-kind items and services | Rystiggo Drug, Neurology | 2025 | |
| 2025-07-24 | ARGENX US, INC. | $1,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VYVGART Drug, Immunology | 2025 | |
| 2025-07-24 | ARGENX US, INC. | $25 | Travel and Lodging | Cash or cash equivalent | VYVGART Drug, Immunology | 2025 | |
| 2025-07-23 | Axsome Therapeutics, Inc. | $1,687 | Honoraria | Cash or cash equivalent | Symbravo Drug, Neurology | 2025 | |
| 2025-07-23 | PFIZER INC. | $7 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-07-23 | PFIZER INC. | $2 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-07-22 | Lundbeck LLC | $19 | Food and Beverage | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2025 | |
| 2025-07-22 | ABBVIE INC. | $11 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-07-21 | ARGENX US, INC. | $24 | Food and Beverage | In-kind items and services | VYVGART Drug, Immunology | 2025 | |
| 2025-07-21 | UCB, Inc. | $10 | Food and Beverage | In-kind items and services | Rystiggo Drug, Neurology | 2025 | |
| 2025-07-17 | ARGENX US, INC. | $1,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VYVGART Drug, Immunology | 2025 | |
| 2025-07-17 | PFIZER INC. | $8 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-07-17 | PFIZER INC. | $1 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-07-15 | ARGENX US, INC. | $21 | Food and Beverage | In-kind items and services | VYVGART Drug, Immunology | 2025 | |
| 2025-07-15 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-07-10 | Axsome Therapeutics, Inc. | $1,650 | Honoraria | Cash or cash equivalent | Symbravo Drug, Neurology | 2025 | |
| 2025-07-10 | Axsome Therapeutics, Inc. | $42 | Travel and Lodging | Cash or cash equivalent | Symbravo Drug, Neurology | 2025 | |
| 2025-07-10 | ARGENX US, INC. | $10 | Food and Beverage | In-kind items and services | VYVGART HYTRULO Drug, Neurology | 2025 | |
| 2025-07-09 | PFIZER INC. | $8 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-07-07 | Lundbeck LLC | $13 | Food and Beverage | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2025 | |
| 2025-07-03 | ARGENX US, INC. | $11 | Food and Beverage | In-kind items and services | VYVGART HYTRULO Drug, Neurology | 2025 | |
| 2025-07-02 | ARGENX US, INC. | $1,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VYVGART Drug, Immunology | 2025 | |
| 2025-07-02 | ARGENX US, INC. | $36 | Travel and Lodging | Cash or cash equivalent | VYVGART Drug, Immunology | 2025 | |
| 2025-07-02 | PFIZER INC. | $8 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-07-02 | PFIZER INC. | $7 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-07-02 | Teva Pharmaceuticals USA, Inc. | $3 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-07-02 | Teva Pharmaceuticals USA, Inc. | $2 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-07-02 | PFIZER INC. | $2 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-07-01 | Axsome Therapeutics, Inc. | $8 | Food and Beverage | In-kind items and services | Symbravo Drug, Neurology | 2025 | |
| 2025-06-26 | Medtronic, Inc. | $22 | Food and Beverage | In-kind items and services | PERCEPT PC BRAINSENSE Device, Deep Brain Neurostimulation | 2025 | |
| 2025-06-25 | Axsome Therapeutics, Inc. | $9 | Food and Beverage | In-kind items and services | Symbravo Drug, Neurology | 2025 | |
| 2025-06-25 | ABBVIE INC. | $7 | Food and Beverage | In-kind items and services | BOTOX Biological, NEUROSCIENCE | 2025 | |
| 2025-06-24 | Lundbeck LLC | $2,000 | Honoraria | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2025 | |
| 2025-06-24 | Lundbeck LLC | $36 | Travel and Lodging | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2025 | |
| 2025-06-23 | ARGENX US, INC. | $2,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VYVGART Drug, Immunology | 2025 | |
| 2025-06-23 | ARGENX US, INC. | $70 | Travel and Lodging | Cash or cash equivalent | VYVGART Drug, Immunology | 2025 | |
| 2025-06-23 | UCB, Inc. | $35 | Food and Beverage | In-kind items and services | Rystiggo Drug, Neurology | 2025 | |
| 2025-06-20 | Celgene Corporation | $14 | Food and Beverage | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2025 | |
| 2025-06-16 | Teva Pharmaceuticals USA, Inc. | $11 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-06-13 | UCB, Inc. | $10 | Food and Beverage | In-kind items and services | Rystiggo Drug, Neurology | 2025 | |
| 2025-06-12 | Lundbeck LLC | $18 | Food and Beverage | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2025 | |
| 2025-06-11 | PFIZER INC. | $11 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-06-05 | Teva Pharmaceuticals USA, Inc. | $27 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-06-05 | ARGENX US, INC. | $10 | Food and Beverage | In-kind items and services | VYVGART HYTRULO Drug, Neurology | 2025 | |
| 2025-06-04 | PFIZER INC. | $8 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-06-04 | PFIZER INC. | $0 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-05-30 | ARGENX US, INC. | $750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VYVGART Drug, Immunology | 2025 | |
| 2025-05-28 | ARGENX US, INC. | $22 | Food and Beverage | In-kind items and services | VYVGART Drug, Immunology | 2025 | |
| 2025-05-28 | Teva Pharmaceuticals USA, Inc. | $10 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-05-21 | ARGENX US, INC. | $19 | Food and Beverage | In-kind items and services | VYVGART HYTRULO Drug, Neurology | 2025 | |
| 2025-05-20 | Celgene Corporation | $11 | Food and Beverage | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2025 | |
| 2025-05-19 | Medtronic, Inc. | $35 | Food and Beverage | In-kind items and services | PERCEPT PC BRAINSENSE Device, Deep Brain Neurostimulation | 2025 | |
| 2025-05-15 | UCB, Inc. | $35 | Food and Beverage | In-kind items and services | Rystiggo Drug, Neurology | 2025 | |
| 2025-05-15 | ARGENX US, INC. | $16 | Food and Beverage | In-kind items and services | VYVGART HYTRULO Drug, Neurology | 2025 | |
| 2025-05-15 | ARGENX US, INC. | $13 | Food and Beverage | In-kind items and services | VYVGART Drug, Immunology | 2025 | |
| 2025-05-14 | PFIZER INC. | $11 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-05-13 | Lundbeck LLC | $2,000 | Honoraria | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2025 | |
| 2025-05-13 | ABBVIE INC. | $11 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-05-12 | Teva Pharmaceuticals USA, Inc. | $16 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-05-12 | ARGENX US, INC. | $15 | Food and Beverage | In-kind items and services | VYVGART Drug, Immunology | 2025 | |
| 2025-05-08 | ARGENX US, INC. | $14 | Food and Beverage | In-kind items and services | VYVGART HYTRULO Drug, Neurology | 2025 | |
| 2025-05-05 | ABBVIE INC. | $3,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-05-05 | UCB, Inc. | $9 | Food and Beverage | In-kind items and services | Rystiggo Drug, Neurology | 2025 | |
| 2025-05-05 | LivaNova USA, Inc. | $3 | Food and Beverage | In-kind items and services | VNS THERAPY SENTIVA MODEL 1000 GENERATOR Device, Neurology | 2025 | |
| 2025-05-03 | Medtronic, Inc. | $29 | Food and Beverage | In-kind items and services | PERCEPT PC BRAINSENSE Device, Deep Brain Neurostimulation | 2025 | |
| 2025-04-30 | PFIZER INC. | $11 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 |
The latest 200 records of 1,843.
Research payments naming this person as principal investigator
| Date | Company | Paid to | Amount | Study | Year |
|---|---|---|---|---|---|
| 2020-09-01 | Novartis Pharmaceuticals Corporation | Aspen Clinical Research | $1,197 | A RANDOMIZED DOUBLE BLIND DOUBLE DUMMY PARALLEL GROUP STUDY COMPARING THE EFFICACY AND SAFETY OF OFATUMUMAB ADMINISTERED | 2020 |
| 2019-08-02 | Biogen, Inc. | ASPEN CLINICAL RESEARCH LLC | $1,445 | Efficacy and Safety of BIIB033 (Opicinumab) as an Add-on Therapy to Disease-Modifying Therapies (DMTs) in Relapsing Mult | 2019 |
| 2019-05-17 | Janssen Research & Development, LLC | Aspen Clinical Research | $429 | AC-058B301 - OPTIMUM | 2019 |
| 2019-02-22 | Janssen Research & Development, LLC | Aspen Clinical Research | $1,169 | AC-058B301 - OPTIMUM | 2019 |
| 2019-02-18 | Novartis Pharmaceuticals Corporation | Aspen Clinical Research | $12,212 | A RANDOMIZED DOUBLE BLIND DOUBLE DUMMY PARALLEL GROUP STUDY COMPARING THE EFFICACY AND SAFETY OF OFATUMUMAB ADMINISTERED | 2019 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Draper, UT, county Salt Lake County, UT, state Utah; placed by its city name.
| Measure | Place (city or town) Draper, UT | County Salt Lake County, UT | State Utah |
|---|---|---|---|
| Population B01003 | 50,278 | 1,196,523 | 3,392,331 |
| Population, 2020 census P1 | 51,017 | 1,185,238 | 3,271,616 |
| Median age B01002 | 34.3 | 34.0 | 32.0 |
| Under 18 B01001 | 28.7% | 25.3% | 27.8% |
| 65 and over B01001 | 10.0% | 11.9% | 11.9% |
| Households B11001 | 16,981 | 426,245 | 1,124,822 |
| Foreign born B05002 | 11.6% | 13.5% | 8.9% |
| Median household income B19013 | $128,910 | $97,494 | $95,166 |
| Median family income B19113 | $144,047 | $116,682 | $109,675 |
| Per capita income B19301 | $58,193 | $45,106 | $40,873 |
| Poverty rate B17001 | 6.1% | 8.1% | 8.5% |
| Unemployment rate B23025 | 2.4% | 3.8% | 3.6% |
| Civilian labor force B23025 | 25,597 | 670,900 | 1,778,106 |
| Mean commute (minutes) B08013 | 24.0 | 22.3 | 22.1 |
| Bachelor's degree or higher B15003 | 51.9% | 39.4% | 37.7% |
| Housing units B25001 | 17,448 | 449,662 | 1,223,468 |
| Owner-occupied B25003 | 68.6% | 66.1% | 70.2% |
| Renters B25003 | 31.4% | 33.9% | 29.8% |
| Median home value B25077 | $784,800 | $525,700 | $489,400 |
| Median gross rent B25064 | $1,894 | $1,592 | $1,496 |
| White, not Hispanic B03002 | 77.0% | 66.6% | 74.7% |
| Black B03002 | 1.8% | 1.7% | 1.1% |
| Hispanic or Latino B03002 | 8.1% | 20.6% | 15.9% |
| Asian B03002 | 6.2% | 4.2% | 2.4% |
| American Indian and Alaska Native B03002 | 0.3% | 0.5% | 0.6% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Draper, UT.
Comments